| Literature DB >> 27472560 |
Jose Lara1,2,3,4, Nicola O'Brien5, Alan Godfrey3,6, Ben Heaven5, Elizabeth H Evans5, Scott Lloyd7,8,9,10, Suzanne Moffatt3,5, Paula J Moynihan1,3,11, Thomas D Meyer12, Lynn Rochester3,6, Falko F Sniehotta5,10, Martin White5,13, John C Mathers1,2,3,14.
Abstract
BACKGROUND: Lifestyle interventions delivered during the retirement transition might promote healthier ageing. We report a pilot randomised controlled trial (RCT) of a web-based platform (Living, Eating, Activity and Planning through retirement; LEAP) promoting healthy eating (based on a Mediterranean diet (MD)), physical activity (PA) and meaningful social roles.Entities:
Mesh:
Year: 2016 PMID: 27472560 PMCID: PMC4966951 DOI: 10.1371/journal.pone.0159703
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of study participants at baseline.
| Control (n = 25) | Intervention (LEAP) (n = 50) | |
|---|---|---|
| 62.0 ± 3.9 (60.6 to 63.4) | 60.9 ± 3.4 (59.9 to 61.9) | |
| 164.8 ± 7.6 (161.3 to 168.2) | 165.9 ± 9.2 (163.5 to 168.4) | |
| 5.9 ± 0.9 (5.6 to 6.3) | 5.9 ± 1.1 (5.6 to 6.2) | |
| Mean ± SD (95% CI) | 5.0 ± 2.9 (3.8 to 6.2) | 5.8±2.4 (4.5 to 6.5) |
| Within the 50% most deprived (n(%)) | 14 (56) | 24 (48) |
| Within the 50% least deprived (n(%)) | 11 (44) | 26 (52) |
| Male | 6 (24) | 12 (24) |
| Female | 19 (76) | 38 (76) |
| Married | 20 (80) | 43 (86) |
| Single | 1 (4) | 1 (2) |
| Divorced | 2 (8) | 4 (8) |
| Widowed | 2 (8) | 2 (4) |
| Never | 12 (48) | 33 (66) |
| Ex-smoker | 13 (52) | 14 (28) |
| Current Smoker | 0 (0) | 3 (6) |
| Retired | 1 (4) | 2 (4) |
| Pre-retirement | 24 (96) | 48 (96) |
* BMR = Basal Metablic Rate estimated using the Oxford equations by Henry et al. (34)
Anthropometric status at baseline and follow-up (8 weeks).
| Control (n = 22) | Intervention (LEAP) (n = 48) | |||
|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | |
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| 73.9 (67.7 to 80.2) | 73.6 (67.5 to 79.8) | 74.2 (69.8 to 78.7) | 73.6 (69.2 to 78.0) | |
| 27.3 (25.4 to 29.3) | 27.2 (25.2 to 29.1) | 26.8 (25.4 to 28.2) | 26.6 (25.2 to 28.0) | |
| 92.3 (87.2 to 97.4) | 91.9 (87.1 to 96.8) | 90.4 (86.8 to 94.1) | 89.5 (85.9 to 93.0) | |
| 25.6 (21.8 to 29.4) | 25.4 (21.6 to 29.2) | 24.7 (22.0 to 27.3) | 24.5 (21.9 to 27.2) | |
| 47.0 (42.3 to 51.7) | 48.3 (44.2 to 52.4) | 49.5 (46.3 to 52.8) | 48.5 (45.7 to 51.3) | |
| 34.2 (31.0 to 37.4) | 33.7 (30.7 to 36.7) | 34.9 (32.7 to 37.1) | 34.0 (31.9 to 36.1) | |
* Estimated using bioelectrical impedance.
Self-reported food intake at baseline and at follow-up (8 weeks).
| Control (n = 22) | Intervention (LEAP) (n = 48) | |||
|---|---|---|---|---|
| Food group (portion/day) | Baseline | Follow-up | Baseline | Follow-up |
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| 2.0 (1.4 to 2.7) | 1.9 (1.2 to 2.5) | 2.2 (1.8 to 2.7) | 2.2 (1.7 to 2.6) | |
| 2.1 (1.3 to 2.9) | 2.0 (1.3 to 2.8) | 2.6 (1.9 to 3.1) | 2.4 (1.9 to 3.0) | |
| 0.9 (0.6 to 1.3) | 0.7 (0.4 to 0.9) | 0.8 (0.5 to 1.0) | 0.7 (0.4 to 0.9) | |
| 0.1 (0.0 to 0.3) | 0.1 (0.0 to 0.2) | 0.3 (0.1 to 0.4) | 0.2 (0.1 to 0.4) | |
| 0.3 (0.0 to 0.6) | 0.4 (-0.2 to 1.0) | 0.5 (0.3 to 0.8) | 0.6 (0.0 to 1.2) | |
| 0.1 (0.0 to 0.2) | 0.1 (0.0 to 0.2) | 0.1 (0.1 to 0.2) | 0.1 (0.1 to 0.2) | |
| 0.2 (0.0 to 0.3) | 0.4 (0.2 to 0.5) | 0.3 (0.2 to 0.4) | 0.3 (0.2 to 0.4) | |
| 0.2 (0.0 to 0.3) | 0.3 (0.1 to 0.5) | 0.2 (0.1 to 0.3) | 0.3 (0.1 to 0.4) | |
| 0.1 (0.0 to 0.1) | 0.0 (0.0 to 0.0) | 0.0 (0.0 to 0.1) | 0.1 (0.1 to 0.1) | |
| 0.9 (0.3 to 1.4) | 1.2 (0.7 to 1.7) | 0.8 (0.5 to 1.2) | 0.7 (0.4 to 1.0) | |
| 1.6 (1.2 to 2.1) | 1.3 (0.8 to 1.4) | 1.1 (0.8 to 1.4) | 0.9 (0.7 to 1.1) | |
| 0.3 (0.1 to 0.4) | 0.2 (0.1 to 0.5) | 0.4 (0.3 to 0.5) | 0.4 (0.3 to 0.5) | |
| 0.4 (0.2 to 0.5) | 0.3 (0.1 to 0.4) | 0.3 (0.2 to 0.4) | 0.3 (0.2 to 0.4) | |
| 11/11 | 8/14 | 21/27 | 21/27 | |
| 3.8 (3.2 to 4.5) | 3.8 (3.1 to 4.5) | 4.7 (4.2 to 5.2) | 4.6 (4.1 to 5.1) | |
Food groups based on the Mediterranean diet score (maximum score = 14) developed for the PREDIMED study [31]
Parameters of ambulatory activity (assessed using accelerometry) at baseline and at follow-up (8 weeks).
| Control | Intervention (LEAP) | |||
|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | |
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| Alpha (α) | 2.49 (2.39 to 2.59) | 2.58 (2.49 to 2.67) | 2.49 (2.40 to 2.56) | 2.52 (2.42 to 2.62) |
| Variability | 0.61 (0.54 to 0.68) | 0.59 (0.52 to 0.65) | 0.62 (0.57 to 0.67) | 0.61 (0.56 to 0.66) |
| Steps (number per day) | 7691 (4586 to 10795) | 7181 (3978 to 10384) | 7056 (4986 to 9126) | 6916 (4909 to 8922) |
| Number of activity bouts per day | 31 (17 to 45) | 32 (16 to 48) | 28 (20 to 36) | 29 (21 to 37) |
| Ambulatory time per day (minutes) | 88 (36 to 140) | 82 (28 to 167) | 81 (45 to 117) | 80 (46 to 114) |
| Longest activity bout spent in walking during the assessment week (seconds) | 1382 (91 to 2856) | 1231 (48 to 2413) | 1302 (473 to 2131) | 1278 (292 to 2264) |
*Values were calculated using 60s threshold [36]. Alpha describes the distribution of ambulatory bouts according to their time and is described by the power law distribution exponent. A lower α indicates that a participant tends to accumulate ambulatory time with a larger proportion of long ambulatory bouts.
** Values were calculated using 60s threshold [36]. Variability was used to represent the ‘within subject’ variability of bout length. This was calculated using a maximum likelihood technique.